Get started
BRAIN BIOTEC NA O.N.BRAIN BIOTEC NA O.N.BRAIN BIOTEC NA O.N.

BRAIN BIOTEC NA O.N.

No trades
See on Supercharts
Overview
Financials News Discussions Technicals Forecast Seasonals

BNN chart


Full chart

Key stats


Market capitalization
‪51.56 M‬ EUR
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.51 EUR
Net income (FY)
‪−11.13 M‬ EUR
Revenue (FY)
‪54.63 M‬ EUR
Shares float
‪10.11 M‬
Beta (1Y)
1.06

Employees


Employees (FY)
307
Change (1Y)
−2 −0.65%
Revenue / Employee (1Y)
‪177.95 K‬ EUR
Net income / Employee (1Y)
‪−36.24 K‬ EUR

About BRAIN BIOTECH AG


Sector
Health Technology
Industry
Biotechnology
CEO
Erik de Vries
Website
brain-biotech.de
Headquarters
Zwingenberg
Founded
1993
ISIN
DE0005203947
FIGI
BBG00BT8SH71
BRAIN Biotech AG is a technology company, which engages in the development and commercialization of bioactives, natural compounds, and proprietary enzymes. It operates through the following segments: BioProducts, BioScience, and BioIncubator. The BioProducts segment consists of the product business with enzymes and other proteins. The BioScience segment offers research-intensive and customized solutions. The BioIncubator segment includes promising research and development projects with high value-added potential. The company was founded by Holger Zinke, Jüngen Eck, and Hans Günter Gassen on September 22, 1993 and is headquartered in Zwingenberg, Germany.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

BNN news



Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Check out other big names from the same industry as BNN.

Frequently Asked Questions


The current price of BNN is 2.30 EUR — it has decreased by −1.31% in the past 24 hours. Watch BRAIN BIOTEC NA O.N. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange BRAIN BIOTEC NA O.N. stocks are traded under the ticker BNN.
BNN stock has fallen by −0.88% compared to the previous week, the month change is a −11.37% fall, over the last year BRAIN BIOTEC NA O.N. has showed a −17.86% decrease.
We've gathered analysts' opinions on BRAIN BIOTEC NA O.N. future price: according to them, BNN price has a max estimate of 10.00 EUR and a min estimate of 4.80 EUR. Watch BNN chart and read a more detailed BRAIN BIOTEC NA O.N. stock forecast: see what analysts think of BRAIN BIOTEC NA O.N. and suggest that you do with its stocks.
BNN reached its all-time high on Jan 29, 2018 with the price of 27.75 EUR, and its all-time low was 0.009 EUR and was reached on Oct 8, 2001. View more price dynamics on BNN chart.
See other stocks reaching their highest and lowest prices.
BNN stock is 1.74% volatile and has beta coefficient of 1.06. Track BRAIN BIOTEC NA O.N. stock price on the chart and check out the list of the most volatile stocks — is BRAIN BIOTEC NA O.N. there?
Today BRAIN BIOTEC NA O.N. has the market capitalization of ‪51.56 M‬, it has increased by 5.86% over the last week.
Yes, you can track BRAIN BIOTEC NA O.N. financials in yearly and quarterly reports right on TradingView.
BNN net income for the last half-year is ‪−6.56 M‬ EUR, while the previous report showed ‪−4.56 M‬ EUR of net income which accounts for −43.85% change. Track more BRAIN BIOTEC NA O.N. financial stats to get the full picture.
No, BNN doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Apr 22, 2025, the company has 307 employees. See our rating of the largest employees — is BRAIN BIOTEC NA O.N. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BRAIN BIOTEC NA O.N. EBITDA is ‪−5.35 M‬ EUR, and current EBITDA margin is −9.43%. See more stats in BRAIN BIOTEC NA O.N. financial statements.
Like other stocks, BNN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BRAIN BIOTEC NA O.N. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BRAIN BIOTEC NA O.N. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BRAIN BIOTEC NA O.N. stock shows the sell signal. See more of BRAIN BIOTEC NA O.N. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.